Serum markers of oxidative stress and assisted reproduction procedures results in infertile patients with polycystic ovary syndrome and controls;Marcadores séricos de estresse oxidativo e resultados dos procedimentos de reprodução assistida em pacientes inférteis com síndrome dos ovários policísticos e controles

Revista Brasileira de Ginecologia e Obstetricia

Volumn 32, Issue 3, 2010, Pages 118-125

  Rodrigues, Jhenifer Kliemchen ^a   Dib, Luciana Azor ^a   Ferriani, Rui Alberto ^a   Jordão Junior, Alceu Afonso ^a   Navarro, Paula Andrea de Albuquerque Sales ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Assisted; Female; Infertility; Ovulation induction; Oxidative stress; Polycystic ovary syndrome; Reproductive techniques

Indexed keywords

EID: 77953665433     PISSN: 01007203     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0100-72032010000300004     Document Type: Article

References (42)

1. The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004;81(1):19-25.
2. Fedorcsák P, Dale PO, Storeng R, Tanbo T, Abyholm T. The impact of obesity and insulin resistance on the outcome of IVF or ICSI in women with polycystic ovarian syndrome. Hum Reprod. 2001;16(6):1086-91.
3. Heijnen EM, Eijkemans MJ, Hughes EG, Laven JS, Macklon NS, Fauser BC. A meta-analysis of outcomes of conventional IVF in women with polycystic ovary syndrome. Hum Reprod Update. 2006;12(1):13-21.
4. Patel SS, Carr BR. Oocyte quality in adult polycystic ovary syndrome. Semin Reprod Med. 2008;26(2):196-203.
5. Sahu B, Ozturk O, Ranierri M, Serhal P. Comparison of oocyte quality and intracytoplasmic sperm injection outcome in women with isolated polycystic ovaries or polycystic ovarian syndrome. Arch Gynecol Obstet. 2008;277(3):239-44.
6. Ferreira EM, Vireque AA, Adona PR, Meirelles FV, Ferriani RA, Navarro PA. Cytoplasmic maturation of bovine oocytes: structural and biochemical modifications and acquisition of developmental competence. Theriogenology. 2009;71(5):836-48.
7. Homburg R, Howles CM. Low-dose FSH therapy for anovulatory infertility associated with polycystic ovary syndrome: rationale, results, reflections and refinements. Hum Reprod Update. 1999;5(5):493-9.
8. Giudice LC. Endometrium in PCOS: implantation and predisposition to endocrine CA. Best Pract Res Clin Endocrinol Metab. 2006;20(2): 235-44.
9. Regan L, Owen EJ, Jacobs HS. Hypersecretion of luteinising hormone, infertility, and miscarriage. Lancet. 1990;336(8724):1141-4.
10. Vieira RC, Barcelos IDES, Ferreira EM, Araújo MCPM, Reis RM, Ferriani RA, et al. Avaliação de anomalias meióticas de oócitos em pacientes com síndrome dos ovários policísticos submetidas à estimulação ovariana. Rev Bras Ginecol Obstet. 2008;30(5):241-7.
11. Zhang X, Li XH, Ma X, Wang ZH, Lu S, Guo YL. Redox-induced apoptosis of human oocytes in resting follicles in vitro. J Soc Gynecol Investig. 2006;13(6):451-8.
12. Hanukoglu I. Antioxidant protective mechanisms against reactive oxygen species (ROS) generated by mitochondrial P450 systems in steroidogenic cells. Drug Metab Rev. 2006;38(1-2):171-96.
13. Murray AA, Molinek MD, Baker SJ, Kojima FN, Smith MF, Hillier SG, et al. Role of ascorbic acid in promoting follicle integrity and survival in intact mouse ovarian follicles in vitro. Reproduction. 2001;121(1):89-96.
14. LaPolt PS, Hong LS. Inhibitory effects of superoxide dismutase and cyclic guanosine 3',5'-monophosphate on estrogen production in cultured rat granulosa cells. Endocrinology. 1995;136(12): 5533-9.
15. Verit FF, Erel O, Kocyigit A. Association of increased total antioxidant capacity and anovulation in nonobese infertile patients with clomiphene citrate-resistant polycystic ovary syndrome. Fertil Steril. 2007;88(2):418-24.
16. Fujii J, Iuchi Y, Okada F. Fundamental roles of reactive oxygen species and protective mechanisms in the female reproductive system. Reprod Biol Endocrinol. 2005;3:43.
17. Navarro PA, Liu L, Keefe DL. In vivo effects of arsenite on meiosis, preimplantation development, and apoptosis in the mouse. Biol Reprod. 2004;70(4):980-5.
18. Navarro PA, Liu L, Ferriani RA, Keefe DL. Arsenite induces aberrations in meiosis that can be prevented by coadministration of N-acetylcysteine in mice. Fertil Steril. 2006;85 Suppl 1: 1187-94.
19. Ruder EH, Hartman TJ, Blumberg J, Goldman MB. Oxidative stress and antioxidants: exposure and impact on female fertility. Hum Reprod Update. 2008;14(4):345-57.
20. Agarwal A, Gupta S, Sekhon L, Shah R. Redox considerations in female reproductive function and assisted reproduction: from molecular mechanisms to health implications. Antioxid Redox Signal. 2008;10(8):1375-403.
21. Appasamy M, Jauniaux E, Serhal P, Al-Qahtani A, Groome NP, Muttukrishna S. Evaluation of the relationship between follicular fluid oxidative stress, ovarian hormones, and response to gonadotropin stimulation. Fertil Steril. 2008;89(4):912-21.
22. Kelly CJ, Speirs A, Gould GW, Petrie JR, Lyall H, Connell JM. Altered vascular function in young women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2002;87(2):742-6.
23. Witko-Sarsat V, Friedlander M, Capeillère-Blandin C, Nguyen-Khoa T, Nguyen AT, Zingraff J, et al. Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int. 1996;49(5):1304-13.
24. Halliwell B, Gutteridge JMC. Free radicals in biology and medicine. 2nd ed. New York: Oxford University Press; 1989.
25. Campos Petean C, Ferriani RA, dos Reis RM, de Moura MD, Jordão AA Jr, Navarro PA. Lipid peroxidation and vitamin E in serum and follicular fluid of infertile women with peritoneal endometriosis submitted to controlled ovarian hyperstimulation: a pilot study. Fertil Steril. 2008;90(6):2080-5.
26. Bornoden WR. Antioxidant nutrients and protection from free radicals. In: Kotsonis FN, Mackey M, Hjelle JJ, editors. Nutritional toxicolgy. New York: Raven Press; 1994. p. 19-48.
27. Nwose EU, Jelinek HF, Richards RS, Kerr PG. The 'vitamin E regeneration system' (VERS) and an algorithm to justify antioxidant supplementation in diabetes-a hypothesis. Med Hypotheses. 2008;70(5):1002-8.
28. de Matos DG, Furnus CC. The importance of having high glutathione (GSH) level after bovine in vitro maturation on embryo development effects of beta-mercaptoethanol, cysteine and cystine. Theriogenology. 2000;53(3):761-71.
29. Kingsley PD, Whitin JC, Cohen HJ, Palis J. Developmental expression of extracellular glutathione peroxidase suggests antioxidant roles in deciduum, visceral yolk sac, and skin. Mol Reprod Dev. 1998;49(4):343-55.
30. Imai H. Biological significance of lipid hydroperoxide and its reducing enzyme, phospholipid hydroperoxide glutathione peroxidase, in mammalian cells. Yakugaku Zasshi. 2004;124(12):937-57.
31. Peñarrubia J, Fábregues F, Manau D, Creus M, Casals G, Casamitjana R, et al. Basal and stimulation day 5 anti-Mullerian hormone serum concentrations as predictors of ovarian response and pregnancy in assisted reproductive technology cycles stimulated with gonadotropin-releasing hormone agonist-gonadotropin treatment. Hum Reprod. 2005;20(4):915-22.
32. Costa CM, Santos RCC, Lima ES. A simple automated procedure for thiol measurement in human serum samples. J Bras Patol Med Lab. 2006;42(5):345-50.
33. Arnaud J, Fortis I, Blachier S, Kia D, Favier A. Simultaneous determination of retinol, alpha-tocopherol and beta-carotene in serum by isocratic high performance liquid chromatography. J Chromatogr. 1991;572(1-2):103-16.
34. DeFronzo RA, Ferrannini E. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care. 1991;14(3):173-94.
35. Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet. 2005;365(9468):1415-28.
36. Vieira CS, Gomes MKO, Rodrigues PC, Pinto APM, Reis RM, Ferriani RA, et al. Avaliação da função das células β pancreáticas através do modelo matemático de HOMA em portadoras de syndrome dos ovários policísticos: comparação entre obesas e não-obesas. Rev Bras Ginecol Obstet. 2007;29(3):141-6.
37. Cano F, García-Velasco JA, Millet A, Remohí J, Simón C, Pellicer A. Oocyte quality in polycystic ovaries revisited: identification of a particular subgroup of women. J Assist Reprod Genet. 1997;14(5):254-61.
38. The Thessaloniki ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Consensus on infertility treatment related to polycystic ovary syndrome. Fertil Steril. 2008;89(3):505-22.
39. Fauser BC, Diedrich K, Devroey P; Evian Annual Reproduction Workshop Group 2007. Predictors of ovarian response: progress towards individualized treatment in ovulation induction and ovarian stimulation. Hum Reprod Update. 2008;14(1): 1-14.
40. Fenkci V, Fenkci S, Yilmazer M, Serteser M. Decreased total antioxidant status and increased oxidative stress in women with polycystic ovary syndrome may contribute to the risk of cardiovascular disease. Fertil Steril. 2003;80(1):123-7.
41. Kaya C, Erkan AF, Cengiz SD, Dünder I, Demirel OE, Bilgihan A. Advanced oxidation protein products are increased in women with polycystic ovary syndrome: relationship with traditional and nontraditional cardiovascular risk factors in patients with polycystic ovary syndrome. Fertil Steril. 2009; 94(4):1372-7.
42. Sabuncu T, Vural H, Harma M, Harma M. Oxidative stress in polycystic ovary syndrome and its contribution to the risk of cardiovascular disease. Clin Biochem. 2001;34(5):407-13.